How to Distinguish Common Plasma Cell Disorders

TL;DR

Multiple myeloma is the most likely diagnosis when monoclonal protein production accompanies hypercalcemia, renal impairment, anemia, and bone lesions, summarized by the CRAB criteria. SPEP identifies an M spike, while its size and the presence or absence of organ damage help distinguish multiple myeloma, MGUS, smoldering myeloma, and Waldenström macroglobulinemia.

Transcript

welcome back to the ninja nerd podcast today we're talking about plasma cell disorders and we've got only one case to go over shouldn't be a crazy difficult topic but we'll go through it and very thorough like we always are yeah yeah there's a couple different ones like types of plasma disorders um but we just have to kind of figure out which is th... Read More

Key Insights

• Multiple myeloma is strongly suggested by the CRAB pattern: hypercalcemia, renal failure, anemia, and bone pain or lesions. The presented patient demonstrates every component through calcium of 12.1, creatinine of 2.3, hemoglobin of 10, and lytic skeletal lesions.
• Hypercalcemia is the likely explanation for the patient's increased thirst, frequent urination, and recent confusion. His confusion improved after hydration, supporting the connection between the elevated calcium level and his neurologic and urinary symptoms within the presented clinical picture.
• The protein gap is calculated as total protein minus albumin. A result greater than four suggests excess non-albumin proteins, and this patient's total protein of 9.5 minus albumin of 3 produces a markedly elevated gap of 6.5.
• Serum protein electrophoresis separates circulating proteins into albumin, alpha-1, alpha-2, beta, and gamma fractions. Plasma cell disorders can produce a sharp monoclonal increase in the gamma region, known as an M spike, reflecting excessive immunoglobulin production.
• Monoclonal gammopathy of undetermined significance is a premalignant condition with an M spike below 3 g/dL and no CRAB-related organ damage. It is generally observed by monitoring SPEP and watching for the later appearance of hypercalcemia, renal failure, anemia, or bone disease.
• Smoldering myeloma is positioned between MGUS and symptomatic multiple myeloma. It has an M spike greater than 3 g/dL without CRAB findings, but progression to organ damage would move the clinical classification toward multiple myeloma.
• Multiple myeloma can produce IgG, IgA, and light chains. The light chains, also called Bence Jones proteins in the discussion, cross the glomerulus and injure the kidneys, providing a mechanism for the patient's acute rise in creatinine.
• Waldenström macroglobulinemia is distinguished clinically by hyperviscosity rather than the CRAB pattern. It produces abundant IgM antibodies, which are described as large pentamers, and their accumulation increases blood viscosity despite also producing an M spike.

Questions & Answers

Q: How do CRAB criteria identify multiple myeloma?

CRAB refers to hypercalcemia, renal failure, anemia, and bone pain or bone lesions. The case demonstrates all four findings: calcium is 12.1, creatinine has increased to 2.3 from a baseline of one, hemoglobin is 10, and skeletal imaging shows lytic lesions in the lumbar spine and skull. This combination strongly supports symptomatic multiple myeloma rather than an asymptomatic monoclonal protein disorder.

Q: What symptoms can hypercalcemia cause in multiple myeloma?

Hypercalcemia can account for the patient's increased thirst, frequent urination, and episodic confusion. The discussion connects confusion with the psychiatric manifestations of elevated calcium and connects increased urination with a diabetes insipidus-like renal effect. His improvement after hydration also fits the clinical interpretation that the calcium elevation contributed to these recent neurologic and urinary symptoms.

Q: How is the protein gap calculated and interpreted?

The protein gap is calculated by subtracting serum albumin from total serum protein. In this case, total protein is 9.5 and albumin is 3, producing a gap of 6.5. The discussion states that the gap should not be greater than four. An elevated result indicates abundant circulating proteins other than albumin, prompting evaluation for excess globulins with serum protein electrophoresis.

Q: What does serum protein electrophoresis show in plasma cell disorders?

Serum protein electrophoresis separates plasma proteins according to properties such as charge and weight. The resulting pattern includes albumin, alpha-1 globulin, alpha-2 globulin, beta globulin, and gamma globulins. Multiple myeloma, MGUS, and Waldenström macroglobulinemia can produce an increased gamma fraction called an M spike, which represents excessive monoclonal protein and helps classify the disorder.

Q: How are MGUS and multiple myeloma distinguished?

MGUS has an M spike below 3 g/dL and lacks CRAB findings, meaning it is not causing the hypercalcemia, renal failure, anemia, or bone disease associated with organ damage. Multiple myeloma has an M spike above 3 g/dL together with CRAB manifestations. MGUS is described as a premalignant condition that is monitored with SPEP and clinical observation rather than treated as symptomatic myeloma.

Q: What is smoldering myeloma?

Smoldering myeloma is an intermediate state between MGUS and symptomatic multiple myeloma. The discussion defines it as an M spike greater than 3 g/dL without CRAB criteria. The monoclonal protein burden is therefore higher than in MGUS, but organ damage has not appeared. Development of CRAB findings would indicate progression from the smoldering state to multiple myeloma.

Q: Why does multiple myeloma cause kidney injury?

Multiple myeloma produces large amounts of antibodies, commonly described here as IgG or IgA, along with smaller light chains. These light chains, called Bence Jones proteins in the discussion, circulate in the blood, cross the glomerulus, and injure the kidneys. This process can produce acute tubular necrosis and helps explain the patient's creatinine increase from a baseline of one to 2.3.

Q: How does Waldenström macroglobulinemia differ from multiple myeloma?

Waldenström macroglobulinemia produces an M spike but is differentiated by hyperviscosity syndrome rather than the CRAB pattern emphasized for multiple myeloma. The disorder produces large quantities of IgM antibodies, which are pentamers and therefore much larger than the monomers or dimers discussed in other plasma cell disorders. Their accumulation makes the blood more viscous and creates a distinct clinical presentation.

Summary & Key Takeaways

• A 65-year-old man presents with fatigue, progressive lumbar pain, thirst, frequent urination, and transient confusion relieved by hydration. Laboratory testing shows anemia, hypercalcemia, renal injury, low albumin, and elevated total protein. A skeletal survey reveals lytic lesions in the lumbar spine and skull, collectively indicating systemic plasma cell disease.

• The protein gap is calculated by subtracting albumin from total protein. His gap is 6.5 g/dL, exceeding the discussed threshold of four and indicating excess circulating proteins other than albumin. Serum protein electrophoresis separates albumin and globulin fractions, helping identify a monoclonal gamma-region elevation called an M spike in this case.

• Multiple myeloma produces immunoglobulins and light chains that can damage organs. The CRAB findings distinguish symptomatic disease from MGUS and smoldering myeloma. MGUS has an M spike below 3 g/dL without CRAB findings, while smoldering myeloma has an M spike above 3 g/dL but no CRAB-related organ damage yet.